Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    evonik-m-2025-09-08

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Menu

    FTX-6058

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fulcrum Reveal Ph 1b Results of Pociredir for Sickle Cell Disease
    Fulcrum Reveal Ph 1b Results of Pociredir for Sickle Cell Disease

    29 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/29/3123076/0/en/Fulcrum-Therapeutics-Announces-Results-from-the-12-mg-Dose-Cohort-of-the-Phase-1b-PIONEER-Trial-of-Pociredir-in-Sickle-Cell-Disease.html

    GLOBENEWSWIRE
    29 Jul 2025
    Share Share
    Fulcrum Shares Ph1b Pociredir Trial Data for Sickle Cell Disease
    Fulcrum Shares Ph1b Pociredir Trial Data for Sickle Cell Disease

    28 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/28/3122814/0/en/Fulcrum-Therapeutics-to-Present-Results-from-the-12-mg-Dose-Cohort-of-the-Phase-1b-PIONEER-Trial-of-Pociredir-in-Sickle-Cell-Disease.html

    GLOBENEWSWIRE
    28 Jul 2025
    Share Share
    Fulcrum Therapeutics Announces Q1 2025 Business Highlights
    Fulcrum Therapeutics Announces Q1 2025 Business Highlights

    01 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/01/3072224/0/en/Fulcrum-Therapeutics-Announces-Recent-Business-Highlights-and-Financial-Results-for-First-Quarter-2025.html

    GLOBENEWSWIRE
    01 May 2025
    Share Share